Search results for: Market Access
Filter search results
Incentives for R&D for New Antimicrobial Drugs
31 August 2011
…the authors increase the likelihood of profitability once the product reaches the market. This includes, first, an Advance Market Commitment (AMC) ‘in the form of a cash “prize” for registration…
The Importance of Diversity of Supply in Rare Diseases Markets
23 January 2025
…can also be associated with iterative pharmaceutical innovation in well-functioning medicine markets. Iterative innovation provides access to multiple therapies of different classes while it expands in-class competition and access to…
The Economics of the Market for Medicines: 2013 Review
26 March 2013
…market for medicines in the UK. His presentation covers the key issues, from drug development through health technology assessment and market access. Economics of the Market for Medicines in the…
Access Mechanisms for Orphan Drugs: A Comparative Study of Selected European Countries
1 November 2009
…before full licensing approval, and requirements for studies after the drug is available on the market. Requirements and practice vary substantially across the seven countries. For example, when access decisions…
Working Towards a Sustainable, Healthy Market for Vaccines: a Comprehensive Framework to Support Policy Dialogue and Decision-Making
1 September 2021
…policies that cut across multiple markets. It helps illustrate how challenges in the global vaccines market may be rooted in multiple factors across a market and how market-shaping interventions aimed…
The Trump Administration’s US Drug Pricing Proposal – What will happen next?
12 June 2025
…access at the point of care. However, delays in market access and price setting may occur in countries close to the threshold set for referencing by the MFN e.g., lowest…
How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine? Where are we 6 Months on?
1 July 2021
…access to technologies will allow other manufacturers to enter the market and ease supply constraints. However, we and others have argued that an IP waiver is highly unlikely to increase…
Financing and Scaling Innovation for the COVID Fight: A Closer Look at Demand-Side Incentives for a Vaccine
1 April 2020
…to offer a predictable market for an effective vaccine that offers both access for all and a reasonable return on investment – de-risking market (commercial) uncertainty while still expecting companies…
Can we “Netflix” the Broken Antibiotics Market?
28 September 2022, 3:00pm
…years, Jason has shaped health economics and market access strategies and evidence for the world’s leading pharmaceutical and biotechnology companies. Following careers in academia, consultancy, industry and government, Jason has…